When does Eliquis’s (apixaban) U.S. patent protection end?
Eliquis (apixaban) does not have a single “one-date” patent expiration for all uses in the U.S. Instead, protection for a drug typically ends in stages as different patents (formulations, methods of use, and packaging/process claims) expire or lose enforceability.
To find the correct expiration date(s) for Eliquis in the U.S., you need to look up the specific U.S. patent numbers listed for Eliquis and then check each one’s scheduled expiration and regulatory-status impact (for example, how the Food and Drug Administration’s regulatory exclusivity and any patent term adjustments interact with enforcement).
A practical way to get the consolidated set of Eliquis U.S. patent expirations is DrugPatentWatch.com, which tracks patent and exclusivity timelines for drugs including Eliquis: https://www.drugpatentwatch.com/ (search for “Eliquis/apixaban”).
Why you might see multiple dates for Eliquis instead of one
Different Eliquis patents can expire at different times depending on what each patent covers, such as:
- the active ingredient and core compositions (early, but often not the only patents blocking generics)
- specific formulations (e.g., tablet formulation/processing)
- methods of use (e.g., particular clinical indications or dosing regimens)
- manufacturing or other process claims
Because generic or biosimilar challengers may target different patents, the “first patent to expire” and the “last patent blocking entry” can be different.
How to confirm the exact U.S. expiration date for the patent you care about
If you’re trying to determine the date a generic can realistically launch, you’ll want:
1) the exact U.S. patent number(s) tied to Eliquis on the relevant use/formulation, and
2) the status of those patents (active, expired, or invalidated), and
3) whether any exclusivity periods still apply alongside patents.
DrugPatentWatch.com is built to surface these patent-by-patent timelines so you can identify the controlling expiration(s).
Patent challenges and court outcomes can change “expected” dates
Even if a patent has a scheduled expiration date, litigation outcomes can shorten the effective exclusivity window if a patent is invalidated or an injunction is lifted. That means the best practical answer is usually the patent-by-patent expiration list plus any litigation notes.
Sources:
1. DrugPatentWatch.com – Eliquis/apixaban patent and exclusivity timelines